Literature DB >> 24145414

Natural killer cell licensing in mice with inducible expression of MHC class I.

Takashi Ebihara1, A Helena Jonsson, Wayne M Yokoyama.   

Abstract

Mouse natural killer (NK) cells acquire effector function by an education process termed "licensing" mediated by inhibitory Ly49 receptors which recognize self-MHC class I. Ly49 receptors can bind to MHC class I on targets (in trans) and also to MHC class I on the NK-cell surface (in cis). Which of these interactions regulates NK-cell licensing is not yet clear. Moreover, there are no clear phenotypic differences between licensed and unlicensed NK cells, perhaps because of the previously limited ability to study NK cells with synchronized licensing. Here, we produced MHC class I-deficient mice with inducible MHC class I consisting of a single-chain trimer (SCT), ovalbumin peptide-β2 microgloblin-H2K(b) (SCT-K(b)). Only NK cells with a Ly49 receptor with specificity for SCT-K(b) were licensed after MHC class I induction. NK cells were localized consistently in red pulp of the spleen during induced NK-cell licensing, and there were no differences in maturation or activation markers on recently licensed NK cells. Although MHC class I-deficient NK cells were licensed in hosts following SCT-K(b) induction, NK cells were not licensed after induced SCT-K(b) expression on NK cells themselves in MHC class I-deficient hosts. Furthermore, hematopoietic cells with induced SCT-K(b) licensed NK cells more efficiently than stromal cells. These data indicate that trans interaction with MHC class I on hematopoietic cells regulates NK-cell licensing, which is not associated with other obvious phenotypic changes.

Entities:  

Keywords:  immunity; lymphocytes; tolerance

Mesh:

Substances:

Year:  2013        PMID: 24145414      PMCID: PMC3831452          DOI: 10.1073/pnas.1318255110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Self-tolerance of natural killer cells.

Authors:  David H Raulet; Russell E Vance
Journal:  Nat Rev Immunol       Date:  2006-07       Impact factor: 53.106

2.  Structural engineering of pMHC reagents for T cell vaccines and diagnostics.

Authors:  Vesselin Mitaksov; Steven M Truscott; Lonnie Lybarger; Janet M Connolly; Ted H Hansen; Daved H Fremont
Journal:  Chem Biol       Date:  2007-08

3.  A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education.

Authors:  Anick Chalifour; Léonardo Scarpellino; Jonathan Back; Petter Brodin; Estelle Devèvre; Frédéric Gros; Frédéric Lévy; Georges Leclercq; Petter Höglund; Friedrich Beermann; Werner Held
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

4.  NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.

Authors:  Bree Foley; Sarah Cooley; Michael R Verneris; Julie Curtsinger; Xianghua Luo; Edmund K Waller; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

5.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells.

Authors:  B P Zambrowicz; A Imamoto; S Fiering; L A Herzenberg; W G Kerr; P Soriano
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.

Authors:  Wim Jennes; Sonja Verheyden; Julie W Mertens; Makhtar Camara; Moussa Seydi; Tandakha N Dieye; Souleymane Mboup; Christian Demanet; Luc Kestens
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

7.  Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment.

Authors:  Nathalie T Joncker; Nataliya Shifrin; Frédéric Delebecque; David H Raulet
Journal:  J Exp Med       Date:  2010-09-06       Impact factor: 14.307

8.  Comparative genomics of natural killer cell receptor gene clusters.

Authors:  James Kelley; Lutz Walter; John Trowsdale
Journal:  PLoS Genet       Date:  2005-08       Impact factor: 5.917

9.  The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.

Authors:  N Matsumoto; M Mitsuki; K Tajima; W M Yokoyama; K Yamamoto
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

10.  Tolerance of NK cells encountering their viral ligand during development.

Authors:  Joseph C Sun; Lewis L Lanier
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

View more
  22 in total

1.  Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness.

Authors:  Djem U Kissiov; Michele Ardolino; Nataliya Tovbis Shifrin; Nathalie T Joncker; David H Raulet
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

2.  Impaired NK-cell education diminishes resistance to murine CMV infection.

Authors:  Hairong Wei; William T Nash; Andrew P Makrigiannis; Michael G Brown
Journal:  Eur J Immunol       Date:  2014-10-01       Impact factor: 5.532

3.  Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development.

Authors:  Amir M Alhajjat; Beverly S Strong; Amanda E Lee; Lucas E Turner; Ram K Wadhwani; John R Ortaldo; Jonathan W Heusel; Aimen F Shaaban
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

4.  Cognate HLA absence in trans diminishes human NK cell education.

Authors:  Vanessa Landtwing; Ana Raykova; Gaetana Pezzino; Vivien Béziat; Emanuela Marcenaro; Claudine Graf; Alessandro Moretta; Riccarda Capaul; Andrea Zbinden; Guido Ferlazzo; Karl-Johan Malmberg; Obinna Chijioke; Christian Münz
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

Review 5.  NK cell self tolerance, responsiveness and missing self recognition.

Authors:  Nataliya Shifrin; David H Raulet; Michele Ardolino
Journal:  Semin Immunol       Date:  2014-03-12       Impact factor: 11.130

6.  Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.

Authors:  Lei Shi; Kang Li; Yizhan Guo; Anirban Banerjee; Qing Wang; Ulrike M Lorenz; Mahmut Parlak; Lucy C Sullivan; Oscar Okwudiri Onyema; Saeed Arefanian; Edward B Stelow; David L Brautigan; Timothy N J Bullock; Michael G Brown; Alexander Sasha Krupnick
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-31       Impact factor: 11.205

7.  Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.

Authors:  Xiang-Yu Zhao; Xing-Xing Yu; Zheng-Li Xu; Xun-Hong Cao; Ming-Rui Huo; Xiao-Su Zhao; Ying-Jun Chang; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Blood Adv       Date:  2019-12-23

Review 8.  Ly49 receptors: innate and adaptive immune paradigms.

Authors:  Mir Munir A Rahim; Megan M Tu; Ahmad Bakur Mahmoud; Andrew Wight; Elias Abou-Samra; Patricia D A Lima; Andrew P Makrigiannis
Journal:  Front Immunol       Date:  2014-04-02       Impact factor: 7.561

Review 9.  Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.

Authors:  William T Nash; Jeffrey Teoh; Hairong Wei; Awndre Gamache; Michael G Brown
Journal:  Front Immunol       Date:  2014-04-16       Impact factor: 7.561

10.  Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

Authors:  Takuya Sekine; David Marin; Kai Cao; Li Li; Pramod Mehta; Hila Shaim; Catherine Sobieski; Roy Jones; Betul Oran; Chitra Hosing; Gabriela Rondon; Abdullah Alsuliman; Silke Paust; Borje Andersson; Uday Popat; Partow Kebriaei; Muharrem Muftuoglu; Rafet Basar; Kayo Kondo; Yago Nieto; Nina Shah; Amanda Olson; Amin Alousi; Enli Liu; Anushruti Sarvaria; Simrit Parmar; Darius Armstrong-James; Nobuhiko Imahashi; Jeffrey Molldrem; Richard Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2016-05-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.